Chunyan Gu - Search Results

Year	Number of Results
2003	1
2005	1
2008	1
2009	2
2010	2
2011	3
2012	2
2014	2
2015	6
2016	8
2017	5
2018	6
2019	13
2020	15
2021	20
2022	16
2023	11
2024	9

1

Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer.

Wang H, Meng Q, Qian J, Li M, Gu C, Yang Y. Wang H, et al. Among authors: gu c. Pharmacol Ther. 2022 Jun;234:108123. doi: 10.1016/j.pharmthera.2022.108123. Epub 2022 Feb 1. Pharmacol Ther. 2022. PMID: 35121000 Review.

2

Alternative splicing and cancer: a systematic review.

Zhang Y, Qian J, Gu C, Yang Y. Zhang Y, et al. Among authors: gu c. Signal Transduct Target Ther. 2021 Feb 24;6(1):78. doi: 10.1038/s41392-021-00486-7. Signal Transduct Target Ther. 2021. PMID: 33623018 Free PMC article.

3

Review on circular RNAs and new insights into their roles in cancer.

Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Tang X, et al. Among authors: gu c. Comput Struct Biotechnol J. 2021 Jan 22;19:910-928. doi: 10.1016/j.csbj.2021.01.018. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 33598105 Free PMC article. Review.

4

Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis.

Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H. Zhao L, et al. Among authors: gu c. J Control Release. 2020 Feb;318:1-15. doi: 10.1016/j.jconrel.2019.12.005. Epub 2019 Dec 10. J Control Release. 2020. PMID: 31830541

5

NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma.

Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M, An X, Liu H, Janz S, Gu C, Wang H, Yang Y. Wei R, et al. Among authors: gu c. Acta Pharm Sin B. 2022 Aug;12(8):3313-3325. doi: 10.1016/j.apsb.2022.01.015. Epub 2022 Jan 29. Acta Pharm Sin B. 2022. PMID: 35967285 Free PMC article.

6

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.

Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, Zhao J, Gao S, Jurczyszyn A, Janz S, Beksac M, Zhan F, Gu C, Yang Y. Jiang F, et al. Among authors: gu c. J Hematol Oncol. 2021 Apr 1;14(1):54. doi: 10.1186/s13045-021-01066-6. J Hematol Oncol. 2021. PMID: 33794982 Free PMC article.

7

Research progress on non-protein-targeted drugs for cancer therapy.

Zhang Y, Lu L, Song F, Zou X, Liu Y, Zheng X, Qian J, Gu C, Huang P, Yang Y. Zhang Y, et al. Among authors: gu c. J Exp Clin Cancer Res. 2023 Mar 14;42(1):62. doi: 10.1186/s13046-023-02635-y. J Exp Clin Cancer Res. 2023. PMID: 36918935 Free PMC article. Review.

8

Research Advances on Acupuncture Analgesia.

Qiao L, Guo M, Qian J, Xu B, Gu C, Yang Y. Qiao L, et al. Among authors: gu c. Am J Chin Med. 2020;48(2):245-258. doi: 10.1142/S0192415X20500135. Epub 2020 Mar 5. Am J Chin Med. 2020. PMID: 32138535 Review.

9

GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer.

Tang C, Ke M, Yu X, Sun S, Luo X, Liu X, Zhou Y, Wang Z, Cui X, Gu C, Yang Y. Tang C, et al. Among authors: gu c. Adv Sci (Weinh). 2023 Sep;10(25):e2301264. doi: 10.1002/advs.202301264. Epub 2023 Jul 13. Adv Sci (Weinh). 2023. PMID: 37439412 Free PMC article.

10

Iron metabolism and its contribution to cancer (Review).

Chen Y, Fan Z, Yang Y, Gu C. Chen Y, et al. Among authors: gu c. Int J Oncol. 2019 Apr;54(4):1143-1154. doi: 10.3892/ijo.2019.4720. Epub 2019 Feb 20. Int J Oncol. 2019. PMID: 30968149 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

114 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year